Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04006730
Other study ID # Local/2018/VC-01
Secondary ID
Status Completed
Phase
First received
Last updated
Start date October 1, 2018
Est. completion date March 14, 2019

Study information

Verified date June 2019
Source Centre Hospitalier Universitaire de Nimes
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The picc line is a central venous catheter inserted peripherally into a deep vein in the arm (cephalic, basilic or axillary) whose distal end is located at the junction of the superior vena cava / atrium. It is installed for a minimum of 7 days (1), and can be stored for up to 6 months or more if it is functional. For treatments with an indication of more than 3 months, it is common practice to place an implantable catheter chamber. The main indications for picc line placement are: long-term antibiotic therapy, parenteral nutrition, chemotherapy or long-term venous approach when difficulties are encountered in applying a peripheral venous route to the patient. Quickly adopted by medical teams, picc lines are not without risk, however, and three complications are mainly reported: catheter obstruction, deep vein thrombosis and infections. In order to avoid any risk of unnecessary complications, it therefore seems appropriate to target the most appropriate device upstream of the procedure according to the provisional indication. An inventory of pharmaceutical interventions carried out during picc line requests would make it possible to lay the foundations for considering actions to be implemented with the various services requesting picc line and proposals for improvement for the follow-up of patients with picc line to reduce the risk of complications.


Recruitment information / eligibility

Status Completed
Enrollment 277
Est. completion date March 14, 2019
Est. primary completion date March 14, 2019
Accepts healthy volunteers No
Gender All
Age group 18 Years to 100 Years
Eligibility Inclusion Criteria: - Patient aged 18 or over, hospitalized at the University Hospital of Nîmes - Benefiting from a pharmaceutical validation of the demand for picc line connected Exclusion Criteria: - The patient is opposed to participating in this study

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
France Chu Nimes Nîmes

Sponsors (1)

Lead Sponsor Collaborator
Centre Hospitalier Universitaire de Nimes

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary estimate the prevalence of requesting pharmaceutical interventions with a criticality greater than or equal to 2 accepted. 2018
See also
  Status Clinical Trial Phase
Recruiting NCT03606863 - Peripheral Parenteral Nutrition vs Conventional Fluid in Colorectal Resection in ERAS Phase 3
Completed NCT00451646 - Study Comparing the Safety and Tolerance of SMOFlipid 20% in Long-term Treatment With Parenteral Nutrition Phase 3
Enrolling by invitation NCT06161350 - The Multi-disciplinary Approach of Children With Feeding Difficulties and Tube Feeding in UZB Between 2000 and 2021
Completed NCT04234152 - Complete Shielding of Multivitamins to Reduce Toxic Peroxides in the Parenteral Nutrition: A Pilot Study N/A
Completed NCT00672854 - Study Comparing a Soybean Oil-Based With an Olive Oil-Based Lipid Emulsion in ICU Patients Requiring TPN Phase 2/Phase 3
Active, not recruiting NCT01839617 - Study Comparing Early and Late Nutrition in Cancer Patients Undergoing Abdominal Surgery N/A
Completed NCT05299099 - Clinical Trial to Evaluate the Safety and Efficacy of IN-C006 Inj. Compared With RCN301 Phase 3
Withdrawn NCT02463812 - Lipid Infusion Following Major Surgery N/A
Completed NCT04816734 - Initial Parenteral Nutrition Education of Parent Assessment Plan N/A
Terminated NCT01814956 - Different Lipid Emulsions in Acute Lung Injury Patients Phase 4
Completed NCT04234490 - Longitudinal Evaluation of the Impact of Parenteral Nutrition
Recruiting NCT05519761 - A Retrospective, Observational, Multicenter Study to Evaluate the Safety and Performance of POLYSITE® and SEESITE® Implantable Ports
Completed NCT00321165 - The AOT (Acridine Orange and Taurolidine) Trial Phase 3
Completed NCT00292279 - The Impact of Omega-3 Fat Emulsion on Clinical Outcome of Post-Operative Cancer Patients Phase 3
Recruiting NCT03157245 - Incidence of Deep Vein Thrombosis on Central Venous Catheters in the Post Operative Period of Carcinologic Surgery N/A
Recruiting NCT03693287 - Personalized vs Standardized PN for Preterm Infants >1250g Phase 4
Completed NCT02828150 - Integrative Parenteral Nutrition in Cancer Patients N/A
Completed NCT00798681 - Evaluating the Influence of Ready-to-use (RTU) Parenteral Nutrition in the Clinical Outcome of Patients Study Phase 4
Completed NCT00512629 - Cholestasis Prevention: Efficacy of IV Fish Oil Phase 1
Completed NCT03792100 - Efficacy & Safety of SmofKabiven Emulsion for Infusion vs Hospital Compounded "All in One" for Parenteral Nutrition Phase 3